Home
/
Gut Health

Understanding Bacteroides uniformis, a Well-Studied Fiber Fermenter

REVIEWED BY
William Maish, MD MBA MPH
Clinical Product Lead
Published
November 4, 2025
Last updated
June 4, 2026
Key takeaway:

Detects the abundance of Bacteroides uniformis in your gut microbiome to reveal imbalances linked to obesity, metabolic syndrome/insulin resistance and gut inflammation; knowing your levels may help you take targeted dietary or probiotic steps to reduce those risks.

Read more →
Table of contents

Bacteroides uniformis: A well-studied fiber fermenter

A Bacteroides uniformis test measures the abundance of a single, well‑studied gut bacterium from a small stool sample. Labs typically quantify this species using species‑specific quantitative PCR or shotgun metagenomic sequencing. Both methods analyze microbial DNA in stool to estimate how much B. uniformis is present relative to the total community, sometimes also reporting absolute copies per gram. While 16S rRNA profiling can describe the broader genus Bacteroides, precise species‑level calls usually rely on metagenomics or qPCR. Results capture your current ecosystem snapshot, which can shift with diet, medications, travel, stress, and illness.

Why this microbe matters: B. uniformis specializes in digesting complex carbohydrates from plants and produces beneficial short‑chain fatty acids that help fuel colon cells, reinforce the gut barrier, and modulate immune tone. Research links its presence to features of metabolic health and balanced inflammation, though effects vary by person and context. Think of it as one player in a larger orchestra—the whole microbiome determines the music—but this instrument often supports a steady rhythm.

What this species adds to your microbiome picture

In real life, you feel your microbiome at the dinner table and the day after. If your gut is light on microbes that thrive on fiber, you may experience sluggish digestion, more gas from fermentation happening in the “wrong” places, or signals of low‑grade inflammation. Measuring B. uniformis helps identify a pattern of dysbiosis where fiber‑degrading capacity is underpowered or, conversely, where a Bacteroides‑dominant profile aligns with high animal fat and low fermentable fiber intake. It also helps assess how recent antibiotics, restrictive dieting, or GI infections may have reshaped your microbial community. This test is especially useful after major dietary shifts, persistent GI symptoms, or when you and your clinician are exploring microbiome contributions to weight, glucose control, or skin flares.

Zooming out, the microbiome influences glucose regulation, lipid metabolism, bile acid recycling, and immune signaling that affects everything from workout recovery to how your skin reacts to stress. Short‑chain fatty acids produced by fiber‑friendly microbes can nudge gut hormones that regulate appetite and glucose, a pathway that overlaps with mechanisms people hear about in the GLP‑1 conversation, though microbiome effects are gentler and require consistent inputs from diet. Repeating microbiome testing over time turns isolated numbers into patterns, showing whether the ecosystem is resilient or easily disrupted. The aim is not to chase a single “perfect” microbe but to understand how your B. uniformis level fits into your broader microbial signature to guide prevention and long‑term wellness.

Reading your B. Uniformis number

Your report typically shows Bacteroides uniformis as a relative abundance percentage and, in some labs, as absolute copies per gram of stool. Many reports compare your values to a reference population to indicate whether your level is lower, typical, or higher than peers. There is no universal “gold standard” range for this species, so interpretations depend on the lab’s method and reference set. In general, balanced microbiomes often feature a moderate presence of B. uniformis alongside good overall diversity and representation of other beneficial groups. That pattern tends to align with efficient fiber breakdown, steady short‑chain fatty acid output, and a calm mucosal immune environment.

If your level is on the lower side, it can suggest reduced capacity to process certain plant polysaccharides, which may correlate with symptoms like irregularity or a tendency toward fluctuating stool texture. If it is relatively high, it may reflect a Bacteroides‑leaning profile often seen with higher fat and protein intake and lower fermentable fiber, though individuals vary widely. Either way, the result is a clue rather than a diagnosis. It points to functional patterns—how your gut community uses the foods you give it—that may be explored with nutrition strategies or clinical evaluation if symptoms persist.

Day-to-day factors that move the number

Context matters. Stool consistency, recent meals, transit time, travel, probiotics, and antibiotics in the last 1–2 months can shift levels. Different assays can yield different numbers, so trends over time in the same lab are more meaningful than any single value. For a fuller picture, consider how your B. uniformis result aligns with other data, such as fecal calprotectin or lactoferrin for inflammation, bile acid markers, or systemic labs like A1C and triglycerides. Emerging studies associate B. uniformis with favorable metabolic and inflammatory profiles, but individual responses differ and more human research is needed. The most useful takeaway is how this species fits into your unique ecosystem and health story today.

FAQs

The Bacteroides uniformis test analyzes the genetic material (DNA/RNA) of bacteria, fungi, and other microorganisms in a stool sample to identify which species are present, their relative abundance, and inferred functional potential (for example metabolic pathways or genes associated with microbial activity).

Results report microbial diversity and balance—showing how abundant Bacteroides uniformis and other taxa are and what functions the community may carry out—but do not diagnose or confirm specific diseases; clinical correlation is required to interpret health implications.

The Bacteroides uniformis test is collected at home using the kit’s small swab or a provided collection vial: you use the swab to take a tiny stool sample or transfer a small amount into the vial according to the kit instructions, then seal the sample and prepare it for return.

Keep the process clean (wash hands before and after, avoid touching other surfaces), clearly label the sample with the required name/date/ID, and follow all kit instructions for storage and shipping exactly — proper collection and handling are essential for accurate sequencing results.

Bacteroides uniformis test results can provide clues about how well your gut is breaking down complex carbohydrates and fiber (digestion), the balance of microbial activity that influences local and systemic inflammation, how efficiently nutrients and certain vitamins are released and absorbed, and aspects of metabolic health such as short‑chain fatty acid production that affect energy use and glucose regulation. Results can also offer indirect information about gut–brain communication because microbial metabolites influence signaling pathways linked to mood, appetite and cognitive function.

These findings are associative: microbiome patterns—including levels of Bacteroides uniformis—can correlate with certain symptoms or risks but do not by themselves diagnose specific diseases. Test results are best interpreted alongside clinical context, symptoms, diet, and other lab data, and discussed with a healthcare professional before making changes to treatment or lifestyle.

Next‑generation sequencing (NGS) methods provide high‑resolution data on microbial DNA and can sensitively detect and quantify Bacteroides uniformis in a sample, but the interpretation is inherently probabilistic: sequencing yields relative abundance estimates and detection depends on sampling, extraction and bioinformatic thresholds, so results indicate likelihoods and trends rather than absolute, deterministic diagnoses.

Test results represent a single snapshot and can change over time — they are influenced by recent diet, stress, bowel habits and especially recent antibiotic use (as well as sample timing and handling), so repeat or longitudinal sampling is often needed to understand meaningful changes.

Many people test their bacteroides uniformis once per year to establish a baseline, or every 3–6 months if they are actively adjusting diet, taking probiotics, or making other interventions that could affect their gut microbiome.

Focus on comparing trends over time rather than treating a single reading as definitive—small short-term fluctuations are common, while consistent changes across multiple tests are more meaningful for assessing the impact of interventions.

Microbial populations, including those of Bacteroides uniformis, can change rapidly—often within days—in response to diet shifts, antibiotics, travel, sleep or stress; however, more stable community patterns typically emerge over weeks to months as the microbiome re‑equilibrates.

If you’re monitoring levels, maintain consistent diet and lifestyle for several weeks to a few months before retesting so results reflect meaningful baseline changes rather than short‑term fluctuations.

References

  1. Gauffin Cano, P., Santacruz, A., Moya, Á., & Sanz, Y. (2012). Bacteroides uniformis CECT 7771 ameliorates metabolic and immunological dysfunction in mice with high-fat-diet induced obesity. PLoS One, 7(7), e41079. https://doi.org/10.1371/journal.pone.0041079
  2. El Kaoutari, A., Armougom, F., Gordon, J. I., Raoult, D., & Henrissat, B. (2013). The abundance and variety of carbohydrate-active enzymes in the human gut microbiota. Nature Reviews Microbiology, 11(7), 497-504. https://doi.org/10.1038/nrmicro3050
  3. Koh, A., De Vadder, F., Kovatcheva-Datchary, P., & Bäckhed, F. (2016). From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. Cell, 165(6), 1332-1345. https://doi.org/10.1016/j.cell.2016.05.041
  4. Lynch, S. V., & Pedersen, O. (2016). The human intestinal microbiome in health and disease. The New England Journal of Medicine, 375(24), 2369-2379. https://doi.org/10.1056/NEJMra1600266
  5. Porcari, S., Mullish, B. H., Asnicar, F., Ng, S. C., Zhao, L., Hansen, R., O'Toole, P. W., Raes, J., Hold, G., Putignani, L., Gasbarrini, A., Segata, N., & Cammarota, G. (2025). International consensus statement on microbiome testing in clinical practice. The Lancet Gastroenterology & Hepatology, 10(2), 154-167. https://doi.org/10.1016/S2468-1253(24)00311-X

Built by the world’s top doctors and scientists

Dr Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

Learn more

Dr Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

Learn more

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

Learn more

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

Learn more
Membership slide 1
Membership slide 1
Membership slide 2
Membership slide 3
1 / 3

Your membership starts here

Annual 100+ biomarker panel

Data dashboard and digital twin

Upload past labs and connect wearables

Personalized health protocol

24/7 care team access

AI companion for all health questions

Marketplace with additional solutions

$199

/year*

Billed annually

HSA/ FSA eligible
Cancel anytime
Results in a week

* Pricing may vary for members in New York and New Jersey